ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

SEEBRI NEOHALER
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

SEEBRI NEOHALER Rx

Generic Name and Formulations:
Glycopyrrolate 15.6mcg; per capsule; dry powder for oral inhalation for use with Neohaler device; contains lactose.

Company:
Sunovion

Therapeutic Use:

Indications for SEEBRI NEOHALER:

Long-term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema.

Adult:

For oral inhalation use only with Neohaler device; do not swallow caps. Administer at the same time of the day (AM + PM). Inhale contents of one capsule (15.6mcg) twice daily.

Children:

Not established.

Warnings/Precautions:

Do not initiate in patients during acutely deteriorating or potentially life-threatening COPD episodes. Not for treating acute symptoms. Do not exceed recommended dose. Discontinue immediately and treat if paradoxical bronchospasm or immediate hypersensitivity reactions occur; use alternative therapy. Severe milk protein hypersensitivity. Narrow-angle glaucoma. Urinary retention. Prostatic hyperplasia. Bladder-neck obstruction. Severe renal impairment, including ESRD requiring dialysis. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Additive effects with concomitant other anticholinergic-containing drugs; avoid.

Pharmacological Class:

Long-acting anticholinergic.

Adverse Reactions:

Upper respiratory tract infection, nasopharyngitis, urinary tract infection, sinusitis, oropharyngeal pain; paradoxical bronchospasm, hypersensitivity reactions.

Generic Availability:

NO

How Supplied:

Blister pack—60 (w. one Neohaler device)

Sign Up for Free e-newsletters